Joint Pain Forum – News you can use!
Ransom gets UK marketing approval for Alateris knee osteoarthritis treatment
June 18, 2007
LONDON (Thomson Financial)
William Ransom & Son PLC said it has received UK marketing approval
from the Medicines and Healthcare products Regulatory Agency for
Alateris, the knee osteoarthritis treatment based on Navamedic ASA's
In March, the natural healthcare company signed a ten-year deal with
Navamedic, a Norwegian pharmaceutical company, to market and distribute
the glucosamine product for the prescription market.
The company said the approval permits Alateris to be promoted as an
effective relief of symptoms in mild to moderate osteoarthritis of the
Map | CONTACT